Back to search

University of Thessaly (UTH)

Ο ρόλος χαμηλών δόσεων γκρελίνης στην έκκριση της αυξητικής ορμόνης σε γυναίκες υπό διάφορες συνθήκες οιστρογονικής επίδρασης

Abstract

dc:description

Ghrelin is a 28-amino acid protein, which is produced mainly in the mucosa of the stomach, but it is also expressed in other tissues. Ghrelin is considered the endogenous ligand for the growth hormone secretagogue receptor. Recent studies have shown that ghrelin affects the reproductive function, mainly through its actions on the pituitary gland and the ovaries. This study was conducted to investigate 1) The role of estrogen in ghrelin-induced secretion of growth hormone, 2) The effect of ghrelin on the secretion of gonadotropins and the role of estrogen and 3) The role of estrogen in ghrelin stimulated secretion of prolactin. Materials and methods: The study included 20 women allocated to group 1 and group 2. Group 1 included 10 healthy women of reproductive age and group 2 10 healthy postmenopausal women. Two submaximal dosages of ghrelin were used. Group 1: All women were investigated in two cycles. In the first cycle (control cycle), an experimental procedure was carried out in the early follicular phase (cycle day 2) and was repeated in the late follicular phase. During both experimental procedures, 2 ml of normal saline was given i.v. as an acute injection (time 0 min) and it was repeated 90 min later (time 90 min). In the second cycle (study cycle), the same experimental procedures were performed as described above, but instead of normal saline, the women were given ghrelin as an acute i.v. injection at the corresponding times at the dose of 0.15 μg/kg (0 min) and 0.30 μg/kg (90 min). In each experimental procedure, blood samples were obtained from all women in relation to (time 0) at -15, 0, 30, 60, 90, 120, 150 and 180 min. Group 2: The women received estradiol valerate per os for 14 days twice, a month apart. At the two time periods of estradiol administration (A and B), four experimental procedures were performed in all women, two with ghrelin administration (Exp 1A and Exp 15A) and two with normal saline administration (Exp 1B and Exp 15B). In particular, Exp 1A and Exp 1B were performed on day 1 of time periods A and B respectively, while Exp 15A and Exp 15B were performed on the day 15 of time periods A and B of the estradiol administration respectively. In Exp 1A and Exp 15A, after overnight fasting, ghrelin was administered to women on day 1 and 15 at a single i.v. dose of 0.15 μg/kg (time 0 min) and a second ghrelin dose of 0.30 μg/kg 90 min later (time 90 min). After one month, the experimental procedures Exp 1B and Exp 15B were performed. These procedures were identical to Exp 1A and Exp 15A in terms of the timing, but instead of ghrelin a single dose of 2 ml saline wasadministered at the corresponding times (0 and 90 min). Blood samples were obtained in all four experimental procedures in relation to (time 0 min) -15, 0, 30, 60, 90, 120, 150 and 180 min. Τotal ghrelin was measured in plasma, while growth hormone, estradiol, progesterone, FSH,LH and prolactin were measured in serum. Hormones were measured by radioimmunoassay or immunoradiometric methods. Statistical analysis was performed using the software packageNCSS 2001. Results: Total plasma ghrelin was increased after the i.v. administration of this hormone in Exp 1A and Exp 15A and was not affected by estrogen. Ghrelin-induced increase in the secretion of growth hormone was similar in the early and the late follicular phase of the cycle (group 1) as well as in Exp1A and Exp15A (group 2). In normally cycling women (group 1), ghrelin was shown to exert a suppressive effect on gonadotropin secretion, particularly in the late follicular phase. However, in postmenopausal women (group 2), ghrelin administration did not affect the secretion of gonadotropins either before (Exp 1A) or after treatment with estradiol (Exp 15A), while it significantly increased serum prolactin levels. The stimulating effect of ghrelin on prolactin secretion was enhanced by the exogenous administration of estrogen. Conclusions: This study shows for the first time that the response of growth hormone to two submaximal doses of ghrelin was similar in the early and the late follicular phase of the normal menstrual cycle or in postmenopausal women treated with estradiol. These results suggest that estradiol does not play a significant role in this action of ghrelin. The study also shows for the first time an inhibitory effect of two small dosages of ghrelin on diurnal secretion of FSH and LH in the late follicular phase of the cycle. Although this inhibitory effect of ghrelin on FSH amd LH levels was not seen in estrogen treated postmenopausal women, it is suggested that estradiol may play a permissive role. Finally, ghrelin stimulated prolactin secretion an effect that was enhanced by estradiol. It is likely that estradiol interacts with ghrelin by affecting its actionon the pituitary gland, but the exact physiological mechanism requires further investigation.

Degree

thesis:*
Grantor dc:publisher
University of Thessaly (UTH)
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Malandri, Maria
  • Μαλανδρή, Μαρία

Subjects

dc:subject × 16

Rights

dc:rights
Statement dc:rights
  • BY
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/47065

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Malandri, Maria; Μαλανδρή, Μαρία. Ο ρόλος χαμηλών δόσεων γκρελίνης στην έκκριση της αυξητικής ορμόνης σε γυναίκες υπό διάφορες συνθήκες οιστρογονικής επίδρασης. University of Thessaly (UTH), 2020. http://hdl.handle.net/10442/hedi/47065